Postmarket Surveillance Under Section 522 of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry and Food and Drug Administration Staff

Information

Type

Guidance

Regulated products

Medical Devices

Published

October 7, 2022

Last updated

October 17, 2022

Description

Guidance document providing information on postmarket surveillance under Section 522 of the Federal Food, Drug, and Cosmetic Act.

Organization

Country / Region

United States

License

Other (Public Domain)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed